tiprankstipranks
Trending News
More News >
QuantumPharm, Inc. (HK:2228)
:2228
Hong Kong Market

QuantumPharm, Inc. (2228) Income Statement

Compare
11 Followers

QuantumPharm, Inc. Income Statement

Last quarter (Q2 2025), QuantumPharm, Inc.'s total revenue was ¥517.08M, an increase of 546.61% from the same quarter last year. In Q2, QuantumPharm, Inc.'s net income was ¥82.80M. See QuantumPharm, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 19
Total Revenue
¥ 266.43M¥ 174.42M¥ 133.35M¥ 62.80M¥ 0.00
Gross Profit
¥ 123.43M¥ 48.24M¥ 66.09M¥ 32.78M¥ 0.00
Operating Expenses
¥ 807.63M¥ 770.55M¥ 591.40M¥ 332.22M¥ 9.88M
Depreciation and Amortization
¥ 83.38M¥ 121.72M¥ 47.97M¥ 23.13M¥ 171.86K
EBITDA
¥ -631.38M¥ -1.78B¥ -1.38B¥ -2.11B¥ -9.84M
Operating Income
¥ -684.21M¥ -722.31M¥ -525.31M¥ -299.43M¥ -9.84M
Other Income/Expenses
¥ -830.66M¥ -1.18B¥ -913.30M¥ -1.84B¥ -13.10M
Pretax Income
¥ -1.51B¥ -1.91B¥ -1.44B¥ -2.14B¥ -22.94M
Net Income
¥ -1.52B¥ -1.91B¥ -1.44B¥ -2.14B¥ -36.03M
Per Share Metrics
Basic EPS
¥ -0.79¥ -0.79¥ -0.59¥ -0.89¥ -0.02
Diluted EPS
¥ -0.79¥ -0.79¥ -0.59¥ -0.89¥ -0.02
Weighted Average Shares Outstanding
1.92B 2.42B 2.42B 2.41B 2.33B
Weighted Average Shares Outstanding (Diluted)
1.93B 2.42B 2.42B 2.41B 2.33B
Currency in CNY

QuantumPharm, Inc. Earnings and Revenue History